ScholarIQanswers from OpenAlex & ORCID
Yoshitsugu Kojima
ResearcherPublications, citations & collaboration network
Yoshitsugu Kojima is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yoshitsugu Kojima have?
ScholarIQindexed works
Yoshitsugu Kojima has 19 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yoshitsugu Kojima have?
ScholarIQcitation count
Yoshitsugu Kojima has 110 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yoshitsugu Kojima?
ScholarIQh-index
Yoshitsugu Kojima has an h-index of 6 in OpenAlex.
What is the i10-index of Yoshitsugu Kojima?
ScholarIQi10-index
Yoshitsugu Kojima has an i10-index of 5 in OpenAlex.
What is the ORCID of Yoshitsugu Kojima?
ScholarIQorcid
The ORCID for Yoshitsugu Kojima is on the source record.
What is the OpenAlex record for Yoshitsugu Kojima?
ScholarIQopenalex
The OpenAlex for Yoshitsugu Kojima is on the source record.
What are the most-cited papers on Yoshitsugu Kojima?
ScholarIQmost cited works
Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database
Takeshi Inoue, Hiromi Sano, Yoshitsugu Kojima, Sakiko Yamada, Osamu Shirakawa
Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan
Nakao Iwata, Ataru Inagaki, Hiromi Sano, Kazunari Niidome, Yoshitsugu Kojima, Sakiko Yamada
Effect of brexpiprazole on control of impulsivity in schizophrenia: A randomized functional magnetic resonance imaging study
T.G. van Erp, Ross A. Baker, Kevin Cox, Takao Okame, Yoshitsugu Kojima, Anna Eramo, Steven G. Potkin
Burden in caregivers of patients with schizophrenia, depression, dementia, and stroke in Japan: comparative analysis of quality of life, work productivity, and qualitative caregiving burden
Yoshitsugu Kojima, Sakiko Yamada, Kunitoshi Kamijima, Kentaro Kogushi, Shunya Ikeda
Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study
Jun Ishigooka, Ken Inada, Kazunari Niidome, Kazuo Aoki, Yoshitsugu Kojima, Shuichi Iwashita, Sakiko Yamada